[The effect of therapeutic gentamycin doses on the enzyme secretion in urine].
8 patients with chronic pyelonephritis were given gentamycin intramuscularly injected in individual dosage during 8-10 days. Here the behaviour of the excretion of protein, alanine aminopeptidase alkaline phosphatase, alpha-glucosidase, gamma-glutamyl transpeptidase and lysozyme with the urine was tested. With the exception of the lysozymuria, which increased only in patients with chronic renal insufficiency, regularly a hyperenzymuria developed. Most distinctly the excretion of the alanine aminopeptidase increased. After initial decrease the excretion of total protein transiently increased after completion of the gentamycin therapy. All the deviations were reversible. From the increased excretion of enzymes may not be concluded to a nephrotoxicity of gentamycin.
D000469:Alkaline Phosphatase / Q000652:urine; D000626:Aminopeptidases / Q000652:urine*; D001192:Arylsulfatases / Q000652:urine; D005260:Female; D005839:Gentamicins / Q000009:adverse effects* / Q000627:therapeutic use; D005959:Glucosidases / Q000652:urine; D005966:Glucuronidase / Q000652:urine; D006801:Humans; D007684:Kidney Tubules / Q000187:drug effects; D008297:Male; D009113:Muramidase / Q000652:urine; D011507:Proteinuria / Q000175:diagnosis; D011704:Pyelonephritis / Q000188:drug therapy; D005723:gamma-Glutamyltransferase / Q000652:urine
D005839:Gentamicins; D005723:gamma-Glutamyltransferase; D000469:Alkaline Phosphatase; D001192:Arylsulfatases; D005959:Glucosidases; D009113:Muramidase; D005966:Glucuronidase; D000626:Aminopeptidases
Der Einfluss therapeutischer Gentamyzindosen auf die Enzymausscheidung im Harn